Status:
UNKNOWN
Far Infrared Therapy on AV Fistula Flow, Endothelial Function and Echocardiography in ESRD Patients
Lead Sponsor:
Taipei Veterans General Hospital, Taiwan
Conditions:
End Stage Renal Disease
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
Vascular access complications are the leading cause of morbidity in hemodialysis (HD) patients, and are responsible for a significant percentage of hospitalization, with annual costs approaching one b...
Detailed Description
For patients with end stage renal disease receiving hemodialysis (HD) treatment, a well-functioning vascular access is necessary for achieving adequate dialysis and improving the quality of life. Amon...
Eligibility Criteria
Inclusion
- (1) age between 18 and 80,
- (2) chronic kidney disease (CKD) stage 5 with clearance of creatinine (CCr) less than 15 ml/min,
- (3) not receiving dialysis or renal transplantation,
- (4) is going to receive creation of AV fistula with the standardized surgical procedures of venous end-to-arterial side anastomosis in the upper extremity.
Exclusion
- (1) creation of AV graft or Perm catheter as the type of vascular access,
- (2) heart failure in NYHA Fc III or IV,
- (3) episode of unstable angina, myocardial infarction, cerebrovascular event or receiving percutaneous coronary intervention therapy (PCI; including angioplasty or placement of stent ) within 3 months prior to screening.
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2011
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01138254
Start Date
November 1 2008
End Date
August 1 2011
Last Update
July 14 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Veterans General Hospital
Taipei, Taiwan, Taiwan, 112